| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |